These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
75-3108137
|
|
State of Incorporation
|
IRS Employer Identification No.
|
|
11825 N. Pennsylvania Street
|
||
Carmel, Indiana 46032
|
(317) 817-6100
|
|
Address of principal executive offices
|
Telephone
|
PART I - FINANCIAL INFORMATION
|
Page
|
|
Financial Statements
|
||
Consolidated Balance Sheet as of March 31, 2011 and December 31, 2010
|
3
|
|
Consolidated Statement of Operations for the three months ended March 31, 2011 and 2010
|
5
|
|
Consolidated Statement of Shareholders’ Equity for the three months ended March 31, 2011 and 2010
|
6
|
|
Consolidated Statement of Cash Flows for the three months ended March 31, 2011 and 2010
|
7
|
|
Notes to Consolidated Financial Statements
|
8
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
43
|
Cautionary Statement Regarding Forward-Looking Statements
|
43
|
|
Overview
|
45
|
|
Critical Accounting Policies
|
47
|
|
Results of Operations
|
47
|
|
Premium Collections
|
64
|
|
Liquidity and Capital Resources
|
70
|
|
Investments
|
75
|
|
Investment in Variable Interest Entities
|
83
|
|
New Accounting Standards
|
85
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
85
|
Item 4.
|
Controls and Procedures
|
85
|
PART II - OTHER INFORMATION
|
||
Item 1.
|
Legal Proceedings
|
85
|
Item 1A.
|
Risk Factors
|
85
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
86
|
Item 5.
|
Other Information
|
86
|
Item 6.
|
Exhibits
|
86
|
March 31,
|
December 31,
|
|||||||
2011
|
2010
|
|||||||
(unaudited)
|
||||||||
Investments:
|
||||||||
Fixed maturities, available for sale, at fair value (amortized cost: March 31, 2011 - $20,343.9; December 31, 2010 - $20,155.8)
|
$ | 20,852.2 | $ | 20,633.9 | ||||
Equity securities at fair value (cost: March 31, 2011 - $104.9;
December 31, 2010 - $68.2)
|
105.4 | 68.1 | ||||||
Mortgage loans
|
1,751.3 | 1,761.2 | ||||||
Policy loans
|
281.6 | 284.4 | ||||||
Trading securities
|
403.1 | 372.6 | ||||||
Investments held by variable interest entities
|
401.6 | 420.9 | ||||||
Other invested assets
|
272.1 | 240.9 | ||||||
Total investments
|
24,067.3 | 23,782.0 | ||||||
Cash and cash equivalents - unrestricted
|
424.6 | 571.9 | ||||||
Cash and cash equivalents held by variable interest entities
|
27.1 | 26.8 | ||||||
Accrued investment income
|
336.7 | 327.8 | ||||||
Present value of future profits
|
970.1 | 1,008.6 | ||||||
Deferred acquisition costs
|
1,766.1 | 1,764.2 | ||||||
Reinsurance receivables
|
3,219.0 | 3,256.3 | ||||||
Income tax assets, net
|
798.9 | 839.4 | ||||||
Assets held in separate accounts
|
18.1 | 17.5 | ||||||
Other assets
|
439.9 | 305.1 | ||||||
Total assets
|
$ | 32,067.8 | $ | 31,899.6 |
March 31,
|
December 31,
|
|||||||
2011
|
2010
|
|||||||
(unaudited)
|
||||||||
Liabilities:
|
||||||||
Liabilities for insurance products:
|
||||||||
Interest-sensitive products
|
$ | 13,161.3 | $ | 13,194.7 | ||||
Traditional products
|
10,357.9 | 10,307.6 | ||||||
Claims payable and other policyholder funds
|
979.0 | 968.7 | ||||||
Liabilities related to separate accounts
|
18.1 | 17.5 | ||||||
Other liabilities
|
643.1 | 496.3 | ||||||
Investment borrowings
|
1,203.8 | 1,204.1 | ||||||
Borrowings related to variable interest entities
|
354.4 | 386.9 | ||||||
Notes payable – direct corporate obligations
|
949.8 | 998.5 | ||||||
Total liabilities
|
27,667.4 | 27,574.3 | ||||||
Commitments and Contingencies
|
||||||||
Shareholders' equity:
|
||||||||
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: March 31, 2011 – 251,404,857; December 31, 2010 – 251,084,174)
|
2.5 | 2.5 | ||||||
Additional paid-in capital
|
4,426.1 | 4,424.2 | ||||||
Accumulated other comprehensive income
|
257.6 | 238.3 | ||||||
Accumulated deficit
|
(285.8 | ) | (339.7 | ) | ||||
Total shareholders' equity
|
4,400.4 | 4,325.3 | ||||||
Total liabilities and shareholders' equity
|
$ | 32,067.8 | $ | 31,899.6 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Revenues:
|
||||||||
Insurance policy income
|
$ | 667.2 | $ | 664.6 | ||||
Net investment income:
|
||||||||
General account assets
|
336.1 | 315.2 | ||||||
Policyholder and reinsurer accounts and other special-purpose portfolios
|
37.4 | 24.0 | ||||||
Realized investment gains (losses):
|
||||||||
Net realized investment gains, excluding impairment losses
|
18.4 | 15.4 | ||||||
Other-than-temporary impairment losses:
|
||||||||
Total other-than-temporary impairment losses
|
(13.3 | ) | (17.7 | ) | ||||
Portion of other-than-temporary impairment losses recognized in accumulated other comprehensive income
|
- | (2.6 | ) | |||||
Net impairment losses recognized
|
(13.3 | ) | (20.3 | ) | ||||
Total realized gains (losses)
|
5.1 | (4.9 | ) | |||||
Fee revenue and other income
|
3.4 | 3.5 | ||||||
Total revenues
|
1,049.2 | 1,002.4 | ||||||
Benefits and expenses:
|
||||||||
Insurance policy benefits
|
683.2 | 699.0 | ||||||
Interest expense
|
29.2 | 27.5 | ||||||
Amortization
|
136.7 | 102.6 | ||||||
Loss on extinguishment of debt
|
1.4 | 1.8 | ||||||
Other operating costs and expenses
|
115.1 | 118.4 | ||||||
Total benefits and expenses
|
965.6 | 949.3 | ||||||
Income before income taxes
|
83.6 | 53.1 | ||||||
Tax expense on period income
|
29.7 | 19.2 | ||||||
Net income
|
$ | 53.9 | $ | 33.9 | ||||
Earnings per common share:
|
||||||||
Basic:
|
||||||||
Weighted average shares outstanding
|
251,121,000 | 250,788,000 | ||||||
Net income
|
$ | .21 | $ | .14 | ||||
Diluted:
|
||||||||
Weighted average shares outstanding
|
307,498,000 | 292,081,000 | ||||||
Net income
|
$ | .19 | $ | .13 |
Common stock and additional
paid-in capital
|
Accumulated other comprehensive
income (loss)
|
Retained earnings (accumulated
deficit)
|
Total
|
|||||||||||||
Balance, December 31, 2009
|
$ | 4,411.3 | $ | (264.3 | ) | $ | (614.6 | ) | $ | 3,532.4 | ||||||
Comprehensive income, net of tax:
|
||||||||||||||||
Net income
|
- | - | 33.9 | 33.9 | ||||||||||||
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense of $78.0)
|
- | 146.2 | - | 146.2 | ||||||||||||
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense of $12.0)
|
- | 21.3 | - | 21.3 | ||||||||||||
Total comprehensive income
|
201.4 | |||||||||||||||
Cumulative effect of accounting change
|
- | (6.2 | ) | (9.7 | ) | (15.9 | ) | |||||||||
Stock option and restricted stock plans
|
2.2 | - | - | 2.2 | ||||||||||||
Balance, March 31, 2010
|
$ | 4,413.5 | $ | (103.0 | ) | $ | (590.4 | ) | $ | 3,720.1 | ||||||
Balance, December 31, 2010
|
$ | 4,426.7 | $ | 238.3 | $ | (339.7 | ) | $ | 4,325.3 | |||||||
Comprehensive income, net of tax:
|
||||||||||||||||
Net income
|
- | - | 53.9 | 53.9 | ||||||||||||
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense of $10.0)
|
- | 16.6 | - | 16.6 | ||||||||||||
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense of $1.5)
|
- | 2.7 | - | 2.7 | ||||||||||||
Total comprehensive income
|
73.2 | |||||||||||||||
Stock option and restricted stock plans
|
1.9 | - | - | 1.9 | ||||||||||||
Balance, March 31, 2011
|
$ | 4,428.6 | $ | 257.6 | $ | (285.8 | ) | $ | 4,400.4 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Cash flows from operating activities:
|
||||||||
Insurance policy income
|
$ | 591.6 | $ | 586.3 | ||||
Net investment income
|
325.2 | 314.6 | ||||||
Fee revenue and other income
|
3.4 | 3.5 | ||||||
Insurance policy benefits
|
(513.9 | ) | (465.7 | ) | ||||
Interest expense
|
(16.2 | ) | (23.5 | ) | ||||
Policy acquisition costs
|
(109.4 | ) | (109.0 | ) | ||||
Other operating costs
|
(124.7 | ) | (123.2 | ) | ||||
Taxes
|
(.7 | ) | (1.9 | ) | ||||
Net cash provided by operating activities
|
155.3 | 181.1 | ||||||
Cash flows from investing activities:
|
||||||||
Sales of investments
|
1,248.1 | 2,194.5 | ||||||
Maturities and redemptions of investments
|
252.9 | 158.3 | ||||||
Purchases of investments
|
(1,661.1 | ) | (2,660.3 | ) | ||||
Net purchases of trading securities
|
(23.6 | ) | (33.8 | ) | ||||
Change in cash and cash equivalents held by variable interest entities
|
(.3 | ) | (17.1 | ) | ||||
Other
|
(5.3 | ) | (2.8 | ) | ||||
Net cash used by investing activities
|
(189.3 | ) | (361.2 | ) | ||||
Cash flows from financing activities:
|
||||||||
Issuance of notes payable, net
|
- | 61.4 | ||||||
Payments on notes payable
|
(50.0 | ) | (64.0 | ) | ||||
Amounts received for deposit products
|
395.3 | 408.6 | ||||||
Withdrawals from deposit products
|
(425.8 | ) | (412.0 | ) | ||||
Investment borrowings and borrowings related to variable interest entities
|
(32.8 | ) | (16.2 | ) | ||||
Net cash used by financing activities
|
(113.3 | ) | (22.2 | ) | ||||
Net decrease in cash and cash equivalents
|
(147.3 | ) | (202.3 | ) | ||||
Cash and cash equivalents, beginning of period
|
571.9 | 523.4 | ||||||
Cash and cash equivalents, end of period
|
$ | 424.6 | $ | 321.1 | ||||
March 31,
|
December 31,
|
|||||||
2011
|
2010
|
|||||||
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment
loss has been recognized
|
$ | .3 | $ | (4.4 | ) | |||
Net unrealized gains (losses) on all other investments
|
511.5 | 476.5 | ||||||
Adjustment to present value of future profits (a)
|
(18.0 | ) | (17.6 | ) | ||||
Adjustment to deferred acquisition costs
|
(85.0 | ) | (76.2 | ) | ||||
Unrecognized net loss related to deferred compensation plan
|
(7.4 | ) | (7.7 | ) | ||||
Deferred income tax liability
|
(143.8 | ) | (132.3 | ) | ||||
Accumulated other comprehensive income
|
$ | 257.6 | $ | 238.3 |
(a)
|
The present value of future profits is the value assigned to the right to receive future cash flows from contracts existing at September 10, 2003 (the date our Predecessor emerged from bankruptcy).
|
Other-than-
|
||||||||||||||||||||
temporary
|
||||||||||||||||||||
impairments
|
||||||||||||||||||||
included in
|
||||||||||||||||||||
Gross
|
Gross
|
accumulated other
|
||||||||||||||||||
Amortized
|
unrealized
|
unrealized
|
Estimated
|
comprehensive
|
||||||||||||||||
cost
|
gains
|
losses
|
fair value
|
income
|
||||||||||||||||
Corporate securities
|
$ | 13,950.1 | $ | 628.2 | $ | (142.9 | ) | $ | 14,435.4 | $ | - | |||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
281.7 | 4.1 | (13.1 | ) | 272.7 | - | ||||||||||||||
States and political subdivisions
|
1,819.6 | 12.7 | (80.6 | ) | 1,751.7 | - | ||||||||||||||
Debt securities issued by foreign governments
|
.8 | .1 | - | .9 | - | |||||||||||||||
Asset-backed securities
|
706.9 | 20.3 | (5.1 | ) | 722.1 | - | ||||||||||||||
Collateralized debt obligations
|
180.2 | 6.0 | - | 186.2 | - | |||||||||||||||
Commercial mortgage-backed securities
|
1,331.3 | 80.2 | (6.5 | ) | 1,405.0 | - | ||||||||||||||
Mortgage pass-through securities
|
27.5 | 1.9 | (.1 | ) | 29.3 | - | ||||||||||||||
Collateralized mortgage obligations
|
2,045.8 | 36.9 | (33.8 | ) | 2,048.9 | (13.7 | ) | |||||||||||||
Total fixed maturities, available for sale
|
$ | 20,343.9 | $ | 790.4 | $ | (282.1 | ) | $ | 20,852.2 | $ | (13.7 | ) |
Estimated
|
||||||||
Amortized
|
fair
|
|||||||
cost
|
value
|
|||||||
(Dollars in millions)
|
||||||||
Due in one year or less
|
$ | 109.6 | $ | 110.8 | ||||
Due after one year through five years
|
1,052.7 | 1,108.5 | ||||||
Due after five years through ten years
|
4,146.7 | 4,400.0 | ||||||
Due after ten years
|
10,743.3 | 10,841.5 | ||||||
Subtotal
|
16,052.3 | 16,460.8 | ||||||
Structured securities
|
4,291.6 | 4,391.4 | ||||||
Total fixed maturities, available for sale
|
$ | 20,343.9 | $ | 20,852.2 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Credit losses on fixed maturity securities, available for sale, beginning of period
|
$ | (6.1 | ) | $ | (27.2 | ) | ||
Add: credit losses on other-than-temporary impairments not previously recognized
|
- | - | ||||||
Less: credit losses on securities sold
|
4.3 | 3.4 | ||||||
Less: credit losses on securities impaired due to intent to sell (a)
|
- | - | ||||||
Add: credit losses on previously impaired securities
|
- | (5.6 | ) | |||||
Less: increases in cash flows expected on previously impaired securities
|
- | - | ||||||
Credit losses on fixed maturity securities, available for sale, end of period
|
$ | (1.8 | ) | $ | (29.4 | ) |
(a)
|
Represents securities for which the amount previously recognized in accumulated other comprehensive income was recognized in earnings because we intend to sell the security or we more likely than not will be required to sell the security before recovery of its amortized cost basis.
|
Less than 12 months
|
12 months or greater
|
Total
|
||||||||||||||||||||||
Fair
|
Unrealized
|
Fair
|
Unrealized
|
Fair
|
Unrealized
|
|||||||||||||||||||
Description of securities
|
value
|
losses
|
value
|
losses
|
value
|
losses
|
||||||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
$ | 206.3 | $ | (13.1 | ) | $ | .3 | $ | - | $ | 206.6 | $ | (13.1 | ) | ||||||||||
States and political subdivisions
|
1,016.2 | (41.5 | ) | 212.7 | (39.1 | ) | 1,228.9 | (80.6 | ) | |||||||||||||||
Corporate securities
|
2,955.2 | (83.0 | ) | 748.3 | (59.9 | ) | 3,703.5 | (142.9 | ) | |||||||||||||||
Asset-backed securities
|
211.2 | (4.1 | ) | 10.5 | (1.0 | ) | 221.7 | (5.1 | ) | |||||||||||||||
Collateralized debt obligations
|
1.7 | - | - | - | 1.7 | - | ||||||||||||||||||
Commercial mortgage-backed securities
|
60.0 | (.7 | ) | 69.0 | (5.8 | ) | 129.0 | (6.5 | ) | |||||||||||||||
Mortgage pass-through securities
|
.2 | - | 3.3 | (.1 | ) | 3.5 | (.1 | ) | ||||||||||||||||
Collateralized mortgage obligations
|
626.5 | (32.6 | ) | 36.4 | (1.2 | ) | 662.9 | (33.8 | ) | |||||||||||||||
Total fixed maturities, available for sale
|
$ | 5,077.3 | $ | (175.0 | ) | $ | 1,080.5 | $ | (107.1 | ) | $ | 6,157.8 | $ | (282.1 | ) |
Less than 12 months
|
12 months or greater
|
Total
|
||||||||||||||||||||||
Fair
|
Unrealized
|
Fair
|
Unrealized
|
Fair
|
Unrealized
|
|||||||||||||||||||
Description of securities
|
value
|
losses
|
value
|
losses
|
value
|
losses
|
||||||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
$ | 196.9 | $ | (11.8 | ) | $ | .2 | $ | - | $ | 197.1 | $ | (11.8 | ) | ||||||||||
States and political subdivisions
|
1,201.9 | (54.8 | ) | 229.6 | (45.9 | ) | 1,431.5 | (100.7 | ) | |||||||||||||||
Corporate securities
|
2,633.0 | (80.6 | ) | 864.6 | (88.4 | ) | 3,497.6 | (169.0 | ) | |||||||||||||||
Asset-backed securities
|
272.2 | (2.4 | ) | 54.0 | (3.9 | ) | 326.2 | (6.3 | ) | |||||||||||||||
Collateralized debt obligations
|
117.0 | (.9 | ) | 5.8 | (.2 | ) | 122.8 | (1.1 | ) | |||||||||||||||
Commercial mortgage-backed securities
|
15.5 | - | 111.8 | (12.5 | ) | 127.3 | (12.5 | ) | ||||||||||||||||
Mortgage pass-through securities
|
.3 | - | 3.4 | - | 3.7 | - | ||||||||||||||||||
Collateralized mortgage obligations
|
661.0 | (29.1 | ) | 112.9 | (6.4 | ) | 773.9 | (35.5 | ) | |||||||||||||||
Total fixed maturities, available for sale
|
$ | 5,097.8 | $ | (179.6 | ) | $ | 1,382.3 | $ | (157.3 | ) | $ | 6,480.1 | $ | (336.9 | ) |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Net income for basic earnings per share
|
$ | 53.9 | $ | 33.9 | ||||
Add: interest expense on 7.0% Convertible Senior Debentures due 2016 (the “7.0% Debentures”), net of income taxes
|
3.7 | 2.6 | ||||||
Net income for diluted earnings per share
|
$ | 57.6 | $ | 36.5 | ||||
Shares:
|
||||||||
Weighted average shares outstanding for basic earnings per share
|
251,121 | 250,788 | ||||||
Effect of dilutive securities on weighted average shares:
|
||||||||
7% Debentures
|
53,367 | 39,533 | ||||||
Stock option and restricted stock plans
|
2,748 | 1,760 | ||||||
Warrants
|
262 | - | ||||||
Dilutive potential common shares
|
56,377 | 41,293 | ||||||
Weighted average shares outstanding for diluted earnings per share
|
307,498 | 292,081 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Revenues:
|
||||||||
Bankers Life:
|
||||||||
Insurance policy income:
|
||||||||
Annuities
|
$ | 8.4 | $ | 8.3 | ||||
Health
|
339.8 | 345.9 | ||||||
Life
|
51.8 | 42.0 | ||||||
Net investment income (a)
|
209.6 | 185.9 | ||||||
Fee revenue and other income (a)
|
2.3 | 2.3 | ||||||
Total Bankers Life revenues
|
611.9 | 584.4 | ||||||
Washington National:
|
||||||||
Insurance policy income:
|
||||||||
Health
|
140.2 | 139.6 | ||||||
Life
|
4.1 | 4.6 | ||||||
Other
|
1.1 | 1.2 | ||||||
Net investment income (a)
|
46.3 | 45.4 | ||||||
Fee revenue and other income (a)
|
.3 | .3 | ||||||
Total Washington National revenues
|
192.0 | 191.1 | ||||||
Colonial Penn:
|
||||||||
Insurance policy income:
|
||||||||
Health
|
1.6 | 1.8 | ||||||
Life
|
48.7 | 46.4 | ||||||
Net investment income (a)
|
10.3 | 9.7 | ||||||
Fee revenue and other income (a)
|
.2 | .2 | ||||||
Total Colonial Penn revenues
|
60.8 | 58.1 | ||||||
Other CNO Business:
|
||||||||
Insurance policy income:
|
||||||||
Annuities
|
2.3 | 2.5 | ||||||
Health
|
7.3 | 7.7 | ||||||
Life
|
61.3 | 63.9 | ||||||
Other
|
.6 | .7 | ||||||
Net investment income (a)
|
94.7 | 92.6 | ||||||
Total Other CNO Business revenues
|
166.2 | 167.4 | ||||||
Corporate operations:
|
||||||||
Net investment income
|
12.6 | 5.6 | ||||||
Fee and other income
|
.6 | .7 | ||||||
Total corporate revenues
|
13.2 | 6.3 | ||||||
Total revenues
|
1,044.1 | 1,007.3 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Expenses:
|
||||||||
Bankers Life:
|
||||||||
Insurance policy benefits
|
$ | 404.8 | $ | 416.5 | ||||
Amortization
|
101.9 | 67.0 | ||||||
Interest expense on investment borrowings
|
1.2 | - | ||||||
Other operating costs and expenses
|
40.1 | 47.7 | ||||||
Total Bankers Life expenses
|
548.0 | 531.2 | ||||||
Washington National:
|
||||||||
Insurance policy benefits
|
112.2 | 112.5 | ||||||
Amortization
|
16.1 | 14.8 | ||||||
Other operating costs and expenses
|
38.5 | 36.2 | ||||||
Total Washington National expenses
|
166.8 | 163.5 | ||||||
Colonial Penn:
|
||||||||
Insurance policy benefits
|
38.7 | 36.7 | ||||||
Amortization
|
9.0 | 8.7 | ||||||
Other operating costs and expenses
|
7.7 | 7.4 | ||||||
Total Colonial Penn expenses
|
55.4 | 52.8 | ||||||
Other CNO Business:
|
||||||||
Insurance policy benefits
|
127.5 | 133.3 | ||||||
Amortization
|
9.1 | 12.2 | ||||||
Interest expense on investment borrowings
|
4.9 | 5.0 | ||||||
Other operating costs and expenses
|
17.6 | 18.8 | ||||||
Total Other CNO Business expenses
|
159.1 | 169.3 | ||||||
Corporate operations:
|
||||||||
Interest expense on corporate debt
|
20.6 | 19.5 | ||||||
Interest expense on borrowings of variable interest entities
|
2.5 | 3.0 | ||||||
Loss on extinguishment of debt
|
1.4 | 1.8 | ||||||
Other operating costs and expenses
|
11.2 | 8.3 | ||||||
Total corporate expenses
|
35.7 | 32.6 | ||||||
Total expenses
|
965.0 | 949.4 | ||||||
Income (loss) before net realized investment losses (net of related amortization) and income taxes:
|
||||||||
Bankers Life
|
63.9 | 53.2 | ||||||
Washington National
|
25.2 | 27.6 | ||||||
Colonial Penn
|
5.4 | 5.3 | ||||||
Other CNO Business
|
7.1 | (1.9 | ) | |||||
Corporate operations
|
(22.5 | ) | (26.3 | ) | ||||
Income before net realized investment losses (net of related amortization) and income taxes
|
$ | 79.1 | $ | 57.9 |
(a)
|
It is not practicable to provide additional components of revenue by product or services.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Total segment revenues
|
$ | 1,044.1 | $ | 1,007.3 | ||||
Net realized investment gains (losses)
|
5.1 | (4.9 | ) | |||||
Consolidated revenues
|
$ | 1,049.2 | $ | 1,002.4 | ||||
Total segment expenses
|
$ | 965.0 | $ | 949.4 | ||||
Amortization related to net realized investment gains (losses)
|
.6 | (.1 | ) | |||||
Consolidated expenses
|
$ | 965.6 | $ | 949.3 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Current tax expense
|
$ | 3.1 | $ | 1.0 | ||||
Deferred tax provision
|
26.6 | 18.2 | ||||||
Total income tax expense
|
$ | 29.7 | $ | 19.2 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
U.S. statutory corporate rate
|
35.0 | % | 35.0 | % | ||||
Other nondeductible benefits
|
(1.0 | ) | (.7 | ) | ||||
State taxes
|
.7 | .9 | ||||||
Provision for tax issues, tax credits and other
|
.8 | 1.0 | ||||||
Effective tax rate
|
35.5 | % | 36.2 | % |
March 31,
|
December 31,
|
|||||||
2011
|
2010
|
|||||||
Deferred tax assets:
|
||||||||
Net federal operating loss carryforwards attributable to:
|
||||||||
Life insurance subsidiaries
|
$ | 651.3 | $ | 681.7 | ||||
Non-life companies
|
877.0 | 870.6 | ||||||
Net state operating loss carryforwards
|
17.8 | 17.8 | ||||||
Tax credits
|
25.2 | 23.4 | ||||||
Capital loss carryforwards
|
343.4 | 339.7 | ||||||
Deductible temporary differences:
|
||||||||
Investments
|
- | 5.3 | ||||||
Insurance liabilities
|
739.5 | 738.9 | ||||||
Other
|
53.2 | 62.8 | ||||||
Gross deferred tax assets
|
2,707.4 | 2,740.2 | ||||||
Deferred tax liabilities:
|
||||||||
Investments
|
(2.4 | ) | - | |||||
Present value of future profits and deferred acquisition costs
|
(667.6 | ) | (676.3 | ) | ||||
Unrealized appreciation on investments
|
(143.8 | ) | (132.3 | ) | ||||
Gross deferred tax liabilities
|
(813.8 | ) | (808.6 | ) | ||||
Net deferred tax assets before valuation allowance
|
1,893.6 | 1,931.6 | ||||||
Valuation allowance
|
(1,081.4 | ) | (1,081.4 | ) | ||||
Net deferred tax assets
|
812.2 | 850.2 | ||||||
Current income taxes accrued
|
(13.3 | ) | (10.8 | ) | ||||
Income tax assets, net
|
$ | 798.9 | $ | 839.4 |
Year of expiration
|
Net operating loss carryforwards (a)
|
Capital loss
|
Total loss
|
|||||||||||||||
Life
|
Non-life
|
carryforwards
|
carryforwards
|
|||||||||||||||
2011
|
$ | - | $ | .1 | $ | - | $ | .1 | ||||||||||
2013
|
- | - | 942.0 | 942.0 | ||||||||||||||
2014
|
- | - | 28.6 | 28.6 | ||||||||||||||
2016
|
- | - | 10.4 | 10.4 | ||||||||||||||
2018
|
1,627.1 |
(a)
|
- | - | 1,627.1 | |||||||||||||
2021
|
29.6 | - | - | 29.6 | ||||||||||||||
2022
|
204.1 | - | - | 204.1 | ||||||||||||||
2023
|
- | 1,999.3 |
(a)
|
- | 1,999.3 | |||||||||||||
2024
|
- | 3.2 | - | 3.2 | ||||||||||||||
2025
|
- | 118.8 | - | 118.8 | ||||||||||||||
2027
|
- | 216.8 | - | 216.8 | ||||||||||||||
2028
|
- | .3 | - | .3 | ||||||||||||||
2029
|
- | 149.0 | - | 149.0 | ||||||||||||||
2031
|
- | 18.3 | - | 18.3 | ||||||||||||||
Total
|
$ | 1,860.8 | $ | 2,505.8 | $ | 981.0 | $ | 5,347.6 |
(a)
|
The allocation of the NOLs summarized above assumes the IRS does not take an adverse position in the future regarding the tax position we plan to take in our tax returns with respect to the allocation of cancellation of indebtedness income. If the IRS disagrees with the tax position we plan to take with respect to the allocation of cancellation of indebtedness income, and their position prevails, approximately $631 million of the NOLs expiring in 2018 would be characterized as non-life NOLs.
|
March 31,
|
December 31,
|
|||||||
2011
|
2010
|
|||||||
7.0% Debentures
|
$ | 293.0 | $ | 293.0 | ||||
Senior Secured Credit Agreement due September 30, 2016 (the “Senior Secured Credit Agreement”)
|
325.0 | 375.0 | ||||||
9.0% Senior Secured Notes due January 2018 (the “9.0% Senior Secured Notes”)
|
275.0 | 275.0 | ||||||
Senior Health Note due November 12, 2013 (the “Senior Health Note”)
|
75.0 | 75.0 | ||||||
Unamortized discount on 7.0% Debentures
|
(14.4 | ) | (14.8 | ) | ||||
Unamortized discount on Senior Secured Credit Agreement
|
(3.8 | ) | (4.7 | ) | ||||
Direct corporate obligations
|
$ | 949.8 | $ | 998.5 |
Remainder of 2011
|
$ | 25.0 | ||
2012
|
45.0 | |||
2013
|
80.0 | |||
2014
|
75.0 | |||
2015
|
85.0 | |||
2016
|
383.0 | |||
2018
|
275.0 | |||
$ | 968.0 |
Amount
|
Maturity
|
Interest rate
|
|||
borrowed
|
date
|
at March 31, 2011
|
|||
$ | 100.0 |
October 2013
|
Variable rate – 0.580%
|
||
67.0 |
February 2014
|
Fixed rate – 1.830%
|
|||
100.0 |
September 2015
|
Variable rate – 0.600%
|
|||
100.0 |
September 2015
|
Variable rate – 0.604%
|
|||
100.0 |
October 2015
|
Variable rate – 0.610%
|
|||
150.0 |
October 2015
|
Variable rate – 0.605%
|
|||
146.0 |
November 2015
|
Fixed rate – 5.300%
|
|||
100.0 |
November 2015
|
Fixed rate – 4.890%
|
|||
100.0 |
December 2015
|
Fixed rate – 4.710%
|
|||
50.0 |
November 2016
|
Variable rate – 0.580%
|
|||
50.0 |
November 2016
|
Variable rate – 0.718%
|
|||
100.0 |
October 2017
|
Variable rate – 0.733%
|
|||
37.0 |
November 2017
|
Fixed rate – 3.750%
|
|||
$ | 1,200.0 |
Balance at December 31, 2010
|
251,084 | ||||
Shares issued under employee benefit compensation plans
|
321 |
(a)
|
|||
Balance at March 31, 2011
|
251,405 |
(a)
|
Such amount was reduced by 149 thousand shares which were tendered to the Company for the payment of federal and state taxes owed on the vesting of restricted stock.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$ | 53.9 | $ | 33.9 | ||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Amortization and depreciation
|
143.3 | 110.4 | ||||||
Income taxes
|
29.0 | 17.3 | ||||||
Insurance liabilities
|
109.1 | 138.4 | ||||||
Accrual and amortization of investment income
|
(48.3 | ) | (24.6 | ) | ||||
Deferral of policy acquisition costs
|
(109.4 | ) | (109.0 | ) | ||||
Net realized investment (gains) losses
|
(5.1 | ) | 4.9 | |||||
Loss on extinguishment of debt
|
1.4 | 1.8 | ||||||
Other
|
(18.6 | ) | 8.0 | |||||
Net cash provided by operating activities
|
$ | 155.3 | $ | 181.1 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Stock option and restricted stock plans
|
$ | 1.9 | $ | 2.2 | ||||
Change in securities lending collateral
|
- | 33.3 | ||||||
Change in securities lending payable
|
- | (33.3 | ) |
March 31, 2011
|
||||||||||||
Fall Creek
|
Net effect on
|
|||||||||||
and
|
consolidated
|
|||||||||||
Eagle Creek
|
Eliminations
|
balance sheet
|
||||||||||
Assets:
|
||||||||||||
Investments held by variable interest entities
|
$ | 401.6 | $ | - | $ | 401.6 | ||||||
Notes receivable of VIEs held by insurance subsidiaries
|
- | (96.8 | ) | (96.8 | ) | |||||||
Cash and cash equivalents held by variable interest entities
|
27.1 | - | 27.1 | |||||||||
Accrued investment income
|
1.3 | (5.3 | ) | (4.0 | ) | |||||||
Income tax assets, net
|
18.0 | (6.5 | ) | 11.5 | ||||||||
Other assets
|
7.8 | - | 7.8 | |||||||||
Total assets
|
$ | 455.8 | $ | (108.6 | ) | $ | 347.2 | |||||
Liabilities:
|
||||||||||||
Other liabilities
|
$ | 19.2 | $ | (5.1 | ) | $ | 14.1 | |||||
Borrowings related to variable interest entities
|
354.4 | - | 354.4 | |||||||||
Notes payable of VIEs held by insurance subsidiaries
|
115.6 | (115.6 | ) | - | ||||||||
Total liabilities
|
$ | 489.2 | $ | (120.7 | ) | $ | 368.5 |
December 31, 2010
|
||||||||||||
Fall Creek
|
Net effect on
|
|||||||||||
and
|
consolidated
|
|||||||||||
Eagle Creek
|
Eliminations
|
balance sheet
|
||||||||||
Assets:
|
||||||||||||
Investments held by variable interest entities
|
$ | 420.9 | $ | - | $ | 420.9 | ||||||
Notes receivable of VIEs held by insurance subsidiaries
|
- | (96.8 | ) | (96.8 | ) | |||||||
Cash and cash equivalents held by variable interest entities
|
26.8 | - | 26.8 | |||||||||
Accrued investment income
|
1.4 | (4.8 | ) | (3.4 | ) | |||||||
Income tax assets, net
|
20.9 | (6.5 | ) | 14.4 | ||||||||
Other assets
|
15.9 | - | 15.9 | |||||||||
Total assets
|
$ | 485.9 | $ | (108.1 | ) | $ | 377.8 | |||||
Liabilities:
|
||||||||||||
Other liabilities
|
$ | 22.0 | $ | (4.6 | ) | $ | 17.4 | |||||
Borrowings related to variable interest entities
|
386.9 | - | 386.9 | |||||||||
Notes payable of VIEs held by insurance subsidiaries
|
115.6 | (115.6 | ) | - | ||||||||
Total liabilities
|
$ | 524.5 | $ | (120.2 | ) | $ | 404.3 |
Estimated
|
||||||||
Amortized
|
fair
|
|||||||
cost
|
value
|
|||||||
(Dollars in millions)
|
||||||||
Due in one year or less
|
$ | 3.1 | $ | 3.1 | ||||
Due after one year through five years
|
287.6 | 287.5 | ||||||
Due after five years through ten years
|
109.2 | 111.0 | ||||||
Total
|
$ | 399.9 | $ | 401.6 |
·
|
Level 1 – includes assets and liabilities valued using inputs that are quoted prices in active markets for identical assets or liabilities. Our Level 1 assets include exchange traded securities.
|
·
|
Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data. Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs such as interest rate, credit spread, reported trades, broker/dealer quotes, issuer spreads and other inputs that are observable or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; and non-exchange-traded derivatives such as call options to hedge liabilities related to our fixed index annuity products.
|
·
|
Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions. Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on non-binding broker prices or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information. Financial instruments in this category include certain corporate securities (primarily private placements), certain mortgage and asset-backed securities, and other less liquid securities. Additionally, the Company’s liabilities for embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) are classified in Level 3 since their values include significant unobservable inputs including actuarial assumptions.
|
Quoted prices in active markets for identical assets or liabilities
(Level 1)
|
Significant other observable inputs
(Level 2)
|
Significant unobservable inputs
(Level 3)
|
Total
|
|||||||||||||||
Assets:
|
||||||||||||||||||
Fixed maturities, available for sale:
|
||||||||||||||||||
Corporate securities
|
$ | - | $ | 12,509.4 | $ | 1,926.0 | $ | 14,435.4 | ||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
- | 271.0 | 1.7 | 272.7 | ||||||||||||||
States and political subdivisions
|
- | 1,742.8 | 8.9 | 1,751.7 | ||||||||||||||
Debt securities issued by foreign governments
|
- | .9 | - | .9 | ||||||||||||||
Asset-backed securities
|
- | 578.8 | 143.3 | 722.1 | ||||||||||||||
Collateralized debt obligations
|
- | - | 186.2 | 186.2 | ||||||||||||||
Commercial mortgage-backed securities
|
- | 1,405.0 | - | 1,405.0 | ||||||||||||||
Mortgage pass-through securities
|
26.0 | - | 3.3 | 29.3 | ||||||||||||||
Collateralized mortgage obligations
|
- | 1,801.4 | 247.5 | 2,048.9 | ||||||||||||||
Total fixed maturities, available for sale
|
26.0 | 18,309.3 | 2,516.9 | 20,852.2 | ||||||||||||||
Equity securities
|
- | 60.0 | 45.4 | 105.4 | ||||||||||||||
Trading securities:
|
||||||||||||||||||
Corporate securities
|
3.5 | 54.8 | 4.6 | 62.9 | ||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
- | 317.5 | - | 317.5 | ||||||||||||||
States and political subdivisions
|
- | 15.9 | - | 15.9 | ||||||||||||||
Asset-backed securities
|
- | .2 | - | .2 | ||||||||||||||
Commercial mortgage-backed securities
|
- | 4.9 | - | 4.9 | ||||||||||||||
Mortgage pass-through securities
|
.3 | - | - | .3 | ||||||||||||||
Collateralized mortgage obligations
|
- | .9 | .5 | 1.4 | ||||||||||||||
Total trading securities
|
3.8 | 394.2 | 5.1 | 403.1 | ||||||||||||||
Investments held by variable interest entities
|
- | 401.6 | - | 401.6 | ||||||||||||||
Other invested assets
|
- | 220.7 |
(a)
|
- | 220.7 | |||||||||||||
Assets held in separate accounts
|
- | 18.1 | - | 18.1 | ||||||||||||||
Liabilities:
|
||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||
Interest-sensitive products
|
- | - | 587.5 |
(b)
|
587.5 |
(a)
|
Includes company-owned life insurance and derivatives.
|
(b)
|
Includes $587.6 million of embedded derivatives associated with our fixed index annuity products and $(.1) million of embedded derivatives associated with a modified coinsurance agreement.
|
Quoted prices in active markets for identical assets or liabilities
(Level 1)
|
Significant other observable inputs
(Level 2)
|
Significant unobservable inputs
(Level 3)
|
Total
|
|||||||||||||||
Assets:
|
||||||||||||||||||
Fixed maturities, available for sale:
|
||||||||||||||||||
Corporate securities
|
$ | - | $ | 12,240.1 | $ | 1,977.5 | $ | 14,217.6 | ||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
10.0 | 282.2 | 2.0 | 294.2 | ||||||||||||||
States and political subdivisions
|
- | 1,772.1 | 11.4 | 1,783.5 | ||||||||||||||
Debt securities issued by foreign governments
|
- | .9 | - | .9 | ||||||||||||||
Asset-backed securities
|
- | 652.7 | 121.0 | 773.7 | ||||||||||||||
Collateralized debt obligations
|
- | - | 256.5 | 256.5 | ||||||||||||||
Commercial mortgage-backed securities
|
- | 1,363.7 | - | 1,363.7 | ||||||||||||||
Mortgage pass-through securities
|
27.8 | - | 3.5 | 31.3 | ||||||||||||||
Collateralized mortgage obligations
|
- | 1,715.4 | 197.1 | 1,912.5 | ||||||||||||||
Total fixed maturities, available for sale
|
37.8 | 18,027.1 | 2,569.0 | 20,633.9 | ||||||||||||||
Equity securities
|
- | 37.5 | 30.6 | 68.1 | ||||||||||||||
Trading securities:
|
||||||||||||||||||
Corporate securities
|
3.2 | 47.5 | 4.3 | 55.0 | ||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
- | 293.8 | - | 293.8 | ||||||||||||||
States and political subdivisions
|
- | 16.1 | - | 16.1 | ||||||||||||||
Asset-backed securities
|
- | .6 | - | .6 | ||||||||||||||
Commercial mortgage-backed securities
|
- | 5.2 | - | 5.2 | ||||||||||||||
Mortgage pass-through securities
|
.3 | - | - | .3 | ||||||||||||||
Collateralized mortgage obligations
|
- | 1.2 | .4 | 1.6 | ||||||||||||||
Total trading securities
|
3.5 | 364.4 | 4.7 | 372.6 | ||||||||||||||
Investments held by variable interest entities
|
- | 414.2 | 6.7 | 420.9 | ||||||||||||||
Other invested assets
|
- | 192.0 |
(a)
|
- | 192.0 | |||||||||||||
Assets held in separate accounts
|
- | 17.5 | - | 17.5 | ||||||||||||||
Liabilities:
|
||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||
Interest-sensitive products
|
- | - | 553.2 |
(b)
|
553.2 |
___
|
____________
|
(a)
|
Includes company-owned life insurance and derivatives.
|
(b)
|
Includes $553.6 million of embedded derivatives associated with our fixed index annuity products and $(.4) million of embedded derivatives associated with a modified coinsurance agreement.
|
March 31, 2011
|
||||||||||||||||||||||||||||||||
Beginning
balance
as of
December 31,
2010
|
Purchases,
sales,
issuances
and
settlements,
net (b)
|
Total
realized
and
unrealized
gains
(losses)
included
in net
income
|
Total realized
and unrealized
gains (losses)
included in
accumulated other
comprehensive
income (loss)
|
Transfers
into
Level 3
(a)
|
Transfers
out of
Level 3
(a)
|
Ending
balance
as of
March 31,
2011
|
Amount of total gains (losses) for the three months ended
March 31, 2011 included
in our net
income relating
to assets and liabilities still held as of the reporting date
|
|||||||||||||||||||||||||
Assets:
|
||||||||||||||||||||||||||||||||
Fixed maturities
,
available for sale:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
$ | 1,977.5 | $ | (63.7 | ) | $ | (11.8 | ) | $ | 9.2 | $ | 14.8 | $ | - | $ | 1,926.0 | $ | - | ||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
2.0 | - | - | (.3 | ) | - | - | 1.7 | - | |||||||||||||||||||||||
States and political subdivisions
|
11.4 | (.1 | ) | - | .1 | - | (2.5 | ) | 8.9 | - | ||||||||||||||||||||||
Asset-backed securities
|
121.0 | (1.2 | ) | - | (.3 | ) | 23.8 | - | 143.3 | - | ||||||||||||||||||||||
Collateralized debt obligations
|
256.5 | (76.7 | ) | 2.1 | 4.3 | - | - | 186.2 | - | |||||||||||||||||||||||
Mortgage pass-through securities
|
3.5 | (.2 | ) | - | - | - | - | 3.3 | - | |||||||||||||||||||||||
Collateralized mortgage obligations
|
197.1 | 11.5 | - | 1.7 | 90.9 | (53.7 | ) | 247.5 | - | |||||||||||||||||||||||
Total fixed maturities,
available for sale
|
2,569.0 | (130.4 | ) | (9.7 | ) | 14.7 | 129.5 | (56.2 | ) | 2,516.9 | - | |||||||||||||||||||||
Equity securities
|
30.6 | 36.6 | - | .7 | - | (22.5 | ) | 45.4 | - | |||||||||||||||||||||||
Trading securities:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
4.3 | - | .3 | - | - | - | 4.6 | .3 | ||||||||||||||||||||||||
Collateralized mortgage
obligations
|
.4 | - | .1 | - | - | - | .5 | .1 | ||||||||||||||||||||||||
Total trading securities
|
4.7 | - | .4 | - | - | - | 5.1 | .4 | ||||||||||||||||||||||||
Investments held by variable interest entities:
|
||||||||||||||||||||||||||||||||
Corporate securities
|
6.7 | (7.9 | ) | 1.5 | (.3 | ) | - | - | - | - | ||||||||||||||||||||||
Liabilities:
|
||||||||||||||||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||||||||||||||||
Interest-sensitive products
|
(553.2 | ) | (36.1 | ) | 1.8 | - | - | - | (587.5 | ) | 1.8 |
(a)
|
Transfers in/out of Level 3 are reported as having occurred at the beginning of the period.
|
(b)
|
Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases and sales of fixed maturity, equity and trading securities, purchases and settlements of derivative instruments, and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts. The following summarizes such activity for the three months ended March 31, 2011 (dollars in millions):
|
Purchases, sales,
issuances and settlements, net
|
||||||||||||
Purchases
|
Sales
|
Issuances
|
Settlements
|
|||||||||
Assets:
|
||||||||||||
Fixed maturities, available for sale:
|
||||||||||||
Corporate securities
|
$ 45.0
|
$(108.7
|
)
|
$ -
|
$ -
|
$ |
(63.7
|
)
|
||||
States and political subdivisions
|
-
|
(.1
|
)
|
-
|
-
|
(.1
|
)
|
|||||
Asset-backed securities
|
-
|
(1.2
|
)
|
-
|
-
|
(1.2
|
)
|
|||||
Collateralized debt obligations
|
1.7
|
(78.4
|
)
|
-
|
-
|
(76.7
|
)
|
|||||
Mortgage pass-through securities
|
-
|
(.2
|
)
|
-
|
-
|
(.2
|
)
|
|||||
Collateralized mortgage obligations
|
18.4
|
(6.9
|
)
|
-
|
-
|
11.5
|
||||||
Total fixed maturities, available for sale
|
65.1
|
(195.5
|
)
|
-
|
-
|
(130.4
|
)
|
|||||
Equity securities
|
36.6
|
-
|
-
|
-
|
36.6
|
|||||||
Investments held by variable interest entities:
|
||||||||||||
Corporate securities
|
-
|
(7.9
|
)
|
-
|
-
|
(7.9
|
)
|
|||||
Liabilities:
|
||||||||||||
Liabilities for insurance products:
|
||||||||||||
Interest-sensitive products
|
(25.0
|
)
|
2.6
|
(19.0
|
)
|
5.3
|
(36.1
|
)
|
March 31, 2010
|
||||||||||||||||||||||||||||||||||||
Beginning
balance
as of
December 31,
2009
|
Cumulative
effect of
accounting
change (a)
|
Purchases,
sales,
issuances
and
settlements,
net
|
Total
realized
and
unrealized
gains
(losses)
included
in net
income
|
Total realized
and unrealized
gains (losses)
included
in other
comprehensive
loss
|
Transfers
into
Level 3
(b)
|
Transfers
out of
Level 3
(b)
|
Ending
balance
as of
March 31,
2010
|
Amount of total gains (losses) for the three months ended
March 31, 2010 included
in our net
income relating
to assets and liabilities still held as of the reporting date
|
||||||||||||||||||||||||||||
Assets:
|
||||||||||||||||||||||||||||||||||||
Fixed maturities, available for sale:
|
||||||||||||||||||||||||||||||||||||
Corporate securities
|
$ | 2,247.1 | $ | (5.9 | ) | $ | (5.1 | ) | $ | - | $ | 16.2 | $ | 25.3 | $ | (27.6 | ) | $ | 2,250.0 | $ | - | |||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
2.2 | - | - | - | - | - | - | 2.2 | - | |||||||||||||||||||||||||||
States and political subdivisions
|
10.7 | - | - | - | - | - | (1.8 | ) | 8.9 | - | ||||||||||||||||||||||||||
Asset-backed securities
|
15.8 | - | (13.0 | ) | (11.3 | ) | 13.4 | - | - | 4.9 | - | |||||||||||||||||||||||||
Collateralized debt obligations
|
92.8 | (5.7 | ) | 38.9 | .6 | 2.3 | - | - | 128.9 | - | ||||||||||||||||||||||||||
Commercial mortgage-backed securities
|
13.7 | - | - | - | .3 | - | (14.0 | ) | - | - | ||||||||||||||||||||||||||
Mortgage pass-through securities
|
4.2 | - | (.2 | ) | - | (.1 | ) | - | - | 3.9 | - | |||||||||||||||||||||||||
Collateralized mortgage obligations
|
11.4 | - | (1.6 | ) | - | .1 | - | - | 9.9 | - | ||||||||||||||||||||||||||
Total fixed maturities, available for sale
|
2,397.9 | (11.6 | ) | 19.0 | (10.7 | ) | 32.2 | 25.3 | (43.4 | ) | 2,408.7 | - | ||||||||||||||||||||||||
Equity securities
|
30.9 | - | - | - | .1 | - | - | 31.0 | - | |||||||||||||||||||||||||||
Trading securities:
|
||||||||||||||||||||||||||||||||||||
Corporate
securities
|
3.7 | - | - | .3 | - | - | - | 4.0 | .3 | |||||||||||||||||||||||||||
Investments held by variable interest entities:
|
||||||||||||||||||||||||||||||||||||
Corporate securities
|
- | 6.9 | - | - | .2 | - | - | 7.1 | - | |||||||||||||||||||||||||||
Securities lending collateral:
|
||||||||||||||||||||||||||||||||||||
Corporate securities
|
13.7 | - | (13.7 | ) | - | - | - | - | - | - | ||||||||||||||||||||||||||
Asset-backed securities
|
22.9 | - | (.8 | ) | - | .1 | - | (.8 | ) | 21.4 | - | |||||||||||||||||||||||||
Total
securities
lending
collateral
|
36.6 | - | (14.5 | ) | - | .1 | - | (.8 | ) | 21.4 | - | |||||||||||||||||||||||||
Other invested
assets
|
2.4 | (2.4 | ) | - | - | - | - | - | - | - | ||||||||||||||||||||||||||
Liabilities:
|
||||||||||||||||||||||||||||||||||||
Liabilities for insurance products:
|
||||||||||||||||||||||||||||||||||||
Interest-
sensitive
products
|
(496.0 | ) | - | 5.6 | (6.8 | ) | - | - | - | (497.2 | ) | (6.8 | ) |
(a)
|
Amounts represent adjustments to investments related to a variable interest entity that was required to be consolidated effective January 1, 2010, as well as the reclassification of investments of a variable interest entity which was consolidated at December 31, 2009.
|
(b)
|
Transfers in/out of Level 3 are reported as having occurred at the beginning of the period.
|
March 31, 2011
|
December 31, 2010
|
|||||||||||||||
Carrying
|
Estimated fair
|
Carrying
|
Estimated fair
|
|||||||||||||
amount
|
value
|
amount
|
value
|
|||||||||||||
Financial assets:
|
||||||||||||||||
Fixed maturities, available for sale
|
$ | 20,852.2 | $ | 20,852.2 | $ | 20,633.9 | $ | 20,633.9 | ||||||||
Equity securities
|
105.4 | 105.4 | 68.1 | 68.1 | ||||||||||||
Mortgage loans
|
1,751.3 | 1,762.1 | 1,761.2 | 1,762.6 | ||||||||||||
Policy loans
|
281.6 | 281.6 | 284.4 | 284.4 | ||||||||||||
Trading securities
|
403.1 | 403.1 | 372.6 | 372.6 | ||||||||||||
Investments held by securitization entities
|
401.6 | 401.6 | 420.9 | 420.9 | ||||||||||||
Other invested assets
|
272.1 | 272.1 | 240.9 | 240.9 | ||||||||||||
Cash and cash equivalents
|
451.7 | 451.7 | 598.7 | 598.7 | ||||||||||||
Financial liabilities:
|
||||||||||||||||
Insurance liabilities for interest-sensitive products (a)
|
$ | 13,161.3 | $ | 13,161.3 | $ | 13,194.7 | $ | 13,194.7 | ||||||||
Investment borrowings
|
1,203.8 | 1,260.7 | 1,204.1 | 1,265.3 | ||||||||||||
Borrowings related to variable interest entities
|
354.4 | 316.6 | 386.9 | 345.1 | ||||||||||||
Notes payable – direct corporate obligations
|
949.8 | 1,154.1 | 998.5 | 1,166.4 |
(a)
|
The estimated fair value of insurance liabilities for interest-sensitive products was approximately equal to its carrying value at March 31, 2011 and December 31, 2010. This was because interest rates credited on the vast majority of account balances approximate current rates paid on similar products and because these rates are not generally guaranteed beyond one year.
|
ITEM 2.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
·
|
changes in or sustained low interest rates causing a reduction in investment income, the margins of our fixed annuity and life insurance business and demand for our products;
|
·
|
general economic, market and political conditions, including the performance and fluctuations of the financial markets which may affect the value of our investments as well as our ability to raise capital or refinance existing indebtedness and the cost of doing so;
|
·
|
the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject;
|
·
|
our ability to make changes to certain non-guaranteed elements of our life insurance products;
|
·
|
our ability to obtain adequate and timely rate increases on our health products, including our long-term care business;
|
·
|
the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries;
|
·
|
mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates and other factors which may affect the profitability of our insurance products;
|
·
|
changes in our assumptions related to deferred acquisition costs or the present value of future profits;
|
·
|
the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on their value;
|
·
|
our assumption that the positions we take on our tax return filings, including our position that our 7.0% Debentures will not be treated as stock for purposes of Section 382 of the Code and will not trigger an ownership change, will not be successfully challenged by the IRS;
|
·
|
changes in accounting principles and the interpretation thereof (including changes in principles related to accounting for deferred acquisition costs);
|
·
|
our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements;
|
·
|
our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems;
|
·
|
performance and valuation of our investments, including the impact of realized losses (including other-than-temporary impairment charges);
|
·
|
our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition;
|
·
|
our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs;
|
·
|
our ability to maintain effective controls over financial reporting;
|
·
|
our ability to continue to recruit and retain productive agents and distribution partners and customer response to new products, distribution channels and marketing initiatives;
|
·
|
our ability to achieve eventual upgrades of the financial strength ratings of CNO and our insurance company subsidiaries as well as the impact of our ratings on our business, our ability to access capital, and the cost of capital;
|
·
|
the risk factors or uncertainties listed from time to time in our filings with the SEC;
|
·
|
regulatory changes or actions, including those relating to regulation of the financial affairs of our insurance companies, such as the payment of dividends and surplus debenture interest to us, regulation of the sale, underwriting and pricing of products, and health care regulation affecting health insurance products; and
|
·
|
changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products or affect the value of our deferred tax assets.
|
·
|
Bankers Life,
which markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents and sales managers supported by a network of community-based branch offices. The Bankers Life segment includes primarily the business of Bankers Life and Casualty Company. Bankers Life also markets and distributes Medicare Advantage plans primarily through a distribution arrangement with Humana and Medicare Part D prescription drug plans through a distribution and reinsurance arrangement with Coventry.
|
|
·
|
Washington National,
which markets and distributes supplemental health (including specified disease, accident and hospital indemnity insurance products) and life insurance to middle-income consumers at home and at the worksite. These products are marketed through Performance Matters Associates, Inc., a wholly owned subsidiary, and through independent marketing organizations and insurance agencies including worksite marketing. The products being marketed are underwritten by Washington National Insurance Company.
|
|
·
|
Colonial Penn , which markets primarily graded benefit and simplified issue life insurance directly to customers through television advertising, direct mail, the internet and telemarketing. The Colonial Penn segment includes primarily the business of Colonial Penn Life Insurance Company. | |
·
|
Other CNO Business,
which consists of blocks of interest-sensitive life insurance, traditional life insurance, annuities, long-term care insurance and other supplemental health products. These blocks of business are not being actively marketed and were primarily issued or acquired by Conseco Life Insurance Company and Washington National Insurance Company.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Earnings before net realized investment gains (losses), corporate interest expense, loss on extinguishment of debt and income taxes (“EBIT” a non-GAAP financial measure) (a):
|
||||||||
Bankers Life
|
$ | 63.9 | $ | 53.2 | ||||
Washington National
|
25.2 | 27.6 | ||||||
Colonial Penn
|
5.4 | 5.3 | ||||||
Other CNO Business
|
7.1 | (1.9 | ) | |||||
Corporate Operations, excluding corporate interest expense
|
(.5 | ) | (5.0 | ) | ||||
EBIT
|
101.1 | 79.2 | ||||||
Corporate interest expense
|
(20.6 | ) | (19.5 | ) | ||||
Income before loss on extinguishment of debt, net realized investment gains (losses) and taxes
|
80.5 | 59.7 | ||||||
Tax expense on operating income
|
28.6 | 21.5 | ||||||
Net operating income
|
51.9 | 38.2 | ||||||
Loss on extinguishment of debt, net of income taxes
|
(.9 | ) | (1.2 | ) | ||||
Net realized investment gains (losses) (net of related amortization and taxes)
|
2.9 | (3.1 | ) | |||||
Net income
|
$ | 53.9 | $ | 33.9 | ||||
Per diluted share:
|
||||||||
Net operating income
|
$ | .18 | $ | .14 | ||||
Net realized investment gains (losses), net of related amortization and taxes
|
.01 | (.01 | ) | |||||
Net income
|
$ | .19 | $ | .13 |
(a)
|
Management believes that an analysis of EBIT provides a clearer comparison of the operating results of the Company from period to period because it excludes: (i) corporate interest expense; (ii) loss on extinguishment of debt; and (iii) net realized investment gains (losses) that are unrelated to the Company’s underlying fundamentals. The table above reconciles the non-GAAP measure to the corresponding GAAP measure.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Income (loss) before net realized investment gains (losses), net of related amortization and income taxes (a non-GAAP measure) (a):
|
||||||||
Bankers Life
|
$ | 63.9 | $ | 53.2 | ||||
Washington National
|
25.2 | 27.6 | ||||||
Colonial Penn
|
5.4 | 5.3 | ||||||
Other CNO Business
|
7.1 | (1.9 | ) | |||||
Corporate operations
|
(22.5 | ) | (26.3 | ) | ||||
79.1 | 57.9 | |||||||
Net realized investment gains (losses), net of related amortization:
|
||||||||
Bankers Life
|
5.6 | (3.5 | ) | |||||
Washington National
|
(.5 | ) | (1.2 | ) | ||||
Colonial Penn
|
1.1 | .5 | ||||||
Other CNO Business
|
(.6 | ) | .7 | |||||
Corporate operations
|
(1.1 | ) | (1.3 | ) | ||||
4.5 | (4.8 | ) | ||||||
Income (loss) before income taxes:
|
||||||||
Bankers Life
|
69.5 | 49.7 | ||||||
Washington National
|
24.7 | 26.4 | ||||||
Colonial Penn
|
6.5 | 5.8 | ||||||
Other CNO Business
|
6.5 | (1.2 | ) | |||||
Corporate operations
|
(23.6 | ) | (27.6 | ) | ||||
Income before income taxes
|
$ | 83.6 | $ | 53.1 |
(a)
|
These non-GAAP measures as presented in the above table and in the following segment financial data and discussions of segment results exclude net realized investment gains (losses), net of related amortization and before income taxes. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Premium collections:
|
||||||||
Annuities
|
$ | 222.2 | $ | 224.2 | ||||
Medicare supplement and other supplemental health
|
337.6 | 347.1 | ||||||
Life
|
56.4 | 46.5 | ||||||
Total collections
|
$ | 616.2 | $ | 617.8 | ||||
Average liabilities for insurance products:
|
||||||||
Annuities:
|
||||||||
Mortality based
|
$ | 245.9 | $ | 251.8 | ||||
Fixed index
|
2,147.7 | 1,685.0 | ||||||
Deposit based
|
4,832.4 | 4,905.3 | ||||||
Medicare supplement and other supplemental health
|
4,489.6 | 4,275.6 | ||||||
Life:
|
||||||||
Interest sensitive
|
420.5 | 407.8 | ||||||
Non-interest sensitive
|
397.8 | 331.4 | ||||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$ | 12,533.9 | $ | 11,856.9 | ||||
Revenues:
|
||||||||
Insurance policy income
|
$ | 400.0 | $ | 396.2 | ||||
Net investment income:
|
||||||||
General account invested assets
|
191.3 | 172.2 | ||||||
Fixed index products
|
18.3 | 12.1 | ||||||
Other special-purpose portfolios
|
- | 1.6 | ||||||
Fee revenue and other income
|
2.3 | 2.3 | ||||||
Total revenues
|
611.9 | 584.4 | ||||||
Expenses:
|
||||||||
Insurance policy benefits
|
337.6 | 350.6 | ||||||
Amounts added to policyholder account balances:
|
||||||||
Annuity products and interest-sensitive life products other than fixed index products
|
40.8 | 43.8 | ||||||
Fixed index products
|
26.4 | 22.1 | ||||||
Amortization related to operations
|
101.9 | 67.0 | ||||||
Interest expense on investment borrowings
|
1.2 | - | ||||||
Other operating costs and expenses
|
40.1 | 47.7 | ||||||
Total benefits and expenses
|
548.0 | 531.2 | ||||||
Income before net realized investment gains (losses), net of related amortization, and income taxes
|
63.9 | 53.2 | ||||||
Net realized investment gains (losses)
|
6.6 | (3.0 | ) | |||||
Amortization related to net realized investment gains (losses)
|
(1.0 | ) | (.5 | ) | ||||
Net realized investment gains (losses), net of related amortization
|
5.6 | (3.5 | ) | |||||
Income before income taxes
|
$ | 69.5 | $ | 49.7 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Health benefit ratios:
|
||||||||
All health lines:
|
||||||||
Insurance policy benefits
|
$ | 297.6 | $ | 311.8 | ||||
Benefit ratio (a)
|
87.6 | % | 90.1 | % | ||||
Medicare supplement:
|
||||||||
Insurance policy benefits
|
$ | 121.7 | $ | 130.2 | ||||
Benefit ratio (a)
|
67.2 | % | 72.8 | % | ||||
PDP:
|
||||||||
Insurance policy benefits
|
$ | 12.9 | $ | 16.0 | ||||
Benefit ratio (a)
|
89.5 | % | 88.7 | % | ||||
PFFS:
|
||||||||
Insurance policy benefits
|
$ | (.7 | ) | $ | (5.1 | ) | ||
Benefit ratio (a)
|
N/A | N/A | ||||||
Long-term care:
|
||||||||
Insurance policy benefits
|
$ | 163.7 | $ | 170.7 | ||||
Benefit ratio (a)
|
113.4 | % | 114.4 | % | ||||
Interest-adjusted benefit ratio (b)
|
70.8 | % | 75.2 | % |
(a)
|
We calculate
benefit
ratios by dividing the related product’s insurance policy benefits by insurance policy income.
|
(b)
|
We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Bankers Life’s long-term care products by dividing such product’s insurance policy benefits less interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Expenses related to the marketing and quota-share agreements with Coventry
|
$ | 2.0 | $ | 5.8 | ||||
Commission expense
|
3.5 | 4.3 | ||||||
Other operating expenses
|
34.6 | 37.6 | ||||||
Total
|
$ | 40.1 | $ | 47.7 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Premium collections:
|
||||||||
Medicare supplement and other supplemental health
|
$ | 142.8 | $ | 141.4 | ||||
Life
|
4.3 | 4.4 | ||||||
Total collections
|
$ | 147.1 | $ | 145.8 | ||||
Average liabilities for insurance products:
|
||||||||
Medicare supplement and other supplemental health
|
$ | 2,434.6 | $ | 2,530.1 | ||||
Non-interest sensitive life
|
205.2 | 206.8 | ||||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$ | 2,639.8 | $ | 2,736.9 | ||||
Revenues:
|
||||||||
Insurance policy income
|
$ | 145.4 | $ | 145.4 | ||||
Net investment income:
|
||||||||
General account invested assets
|
46.3 | 45.5 | ||||||
Trading account income related to reinsurer accounts
|
.3 | .8 | ||||||
Change in value of embedded derivatives related to modified coinsurance agreements
|
(.3 | ) | (.9 | ) | ||||
Fee revenue and other income
|
.3 | .3 | ||||||
Total revenues
|
192.0 | 191.1 | ||||||
Expenses:
|
||||||||
Insurance policy benefits
|
112.2 | 112.5 | ||||||
Amortization related to operations
|
16.1 | 14.8 | ||||||
Other operating costs and expenses
|
38.5 | 36.2 | ||||||
Total benefits and expenses
|
166.8 | 163.5 | ||||||
Income before net realized investment losses and income taxes
|
25.2 | 27.6 | ||||||
Net realized investment losses
|
(.5 | ) | (1.2 | ) | ||||
Income before income taxes
|
$ | 24.7 | $ | 26.4 | ||||
Health benefit ratios:
|
||||||||
All health lines:
|
||||||||
Insurance policy benefits
|
$ | 107.3 | $ | 109.4 | ||||
Benefit ratio (a)
|
76.0 | % | 77.7 | % | ||||
Medicare supplement:
|
||||||||
Insurance policy benefits
|
$ | 23.5 | $ | 27.4 | ||||
Benefit ratio (a)
|
66.3 | % | 65.7 | % | ||||
Supplemental health:
|
||||||||
Insurance policy benefits
|
$ | 82.4 | $ | 80.6 | ||||
Benefit ratio (a)
|
78.7 | % | 82.3 | % | ||||
Interest-adjusted benefit ratio (b)
|
49.1 | % | 49.4 | % | ||||
Other health:
|
||||||||
Insurance policy benefits
|
$ | 1.4 | $ | 1.4 | ||||
Benefit ratio (a)
|
123.2 | % | 118.4 | % | ||||
(a)
|
We calculate
benefit
ratios by dividing the related product’s insurance policy benefits by insurance policy income.
|
(b)
|
We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Washington National’s supplemental health products by dividing such product’s insurance policy benefits less interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Premium collections:
|
||||||||
Life
|
$ | 49.4 | $ | 47.3 | ||||
Supplemental health
|
1.5 | 1.6 | ||||||
Total collections
|
$ | 50.9 | $ | 48.9 | ||||
Average liabilities for insurance products:
|
||||||||
Annuities-mortality based
|
$ | 78.5 | $ | 79.9 | ||||
Supplemental health
|
16.6 | 18.3 | ||||||
Life:
|
||||||||
Interest sensitive
|
20.7 | 21.9 | ||||||
Non-interest sensitive
|
586.7 | 576.6 | ||||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$ | 702.5 | $ | 696.7 | ||||
Revenues:
|
||||||||
Insurance policy income
|
$ | 50.3 | $ | 48.2 | ||||
Net investment income:
|
||||||||
General account invested assets
|
10.3 | 9.7 | ||||||
Fee revenue and other income
|
.2 | .2 | ||||||
Total revenues
|
60.8 | 58.1 | ||||||
Expenses:
|
||||||||
Insurance policy benefits
|
38.5 | 36.4 | ||||||
Amounts added to annuity and interest-sensitive life product account balances
|
.2 | .3 | ||||||
Amortization related to operations
|
9.0 | 8.7 | ||||||
Other operating costs and expenses
|
7.7 | 7.4 | ||||||
Total benefits and expenses
|
55.4 | 52.8 | ||||||
Income before net realized investment gains and income taxes
|
5.4 | 5.3 | ||||||
Net realized investment gains
|
1.1 | .5 | ||||||
Income before income taxes
|
$ | 6.5 | $ | 5.8 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Premium collections:
|
||||||||
Annuities
|
$ | 4.2 | $ | 5.1 | ||||
Other health
|
8.0 | 8.4 | ||||||
Life
|
46.4 | 50.2 | ||||||
Total collections
|
$ | 58.6 | $ | 63.7 | ||||
Average liabilities for insurance products:
|
||||||||
Annuities:
|
||||||||
Mortality based
|
$ | 207.8 | $ | 212.0 | ||||
Fixed index
|
652.1 | 743.6 | ||||||
Deposit based
|
692.0 | 620.0 | ||||||
Separate accounts
|
17.8 | 17.1 | ||||||
Other health
|
481.8 | 480.9 | ||||||
Life:
|
||||||||
Interest sensitive
|
2,527.4 | 2,607.2 | ||||||
Non-interest sensitive
|
805.6 | 844.9 | ||||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$ | 5,384.5 | $ | 5,525.7 | ||||
Revenues:
|
||||||||
Insurance policy income
|
$ | 71.5 | $ | 74.8 | ||||
Net investment income:
|
||||||||
General account invested assets
|
88.2 | 87.8 | ||||||
Fixed index products
|
5.0 | 3.9 | ||||||
Trading account income related to policyholder accounts
|
1.5 | .9 | ||||||
Total revenues
|
166.2 | 167.4 | ||||||
Expenses:
|
||||||||
Insurance policy benefits
|
88.8 | 90.3 | ||||||
Amounts added to policyholder account balances:
|
||||||||
Annuity products and interest-sensitive life products other than fixed index products
|
31.6 | 32.4 | ||||||
Fixed index products
|
7.1 | 10.6 | ||||||
Amortization related to operations
|
9.1 | 12.2 | ||||||
Interest expense on investment borrowings
|
4.9 | 5.0 | ||||||
Other operating costs and expenses
|
17.6 | 18.8 | ||||||
Total benefits and expenses
|
159.1 | 169.3 | ||||||
Income (loss) before net realized investment losses, net of related amortization, and income taxes
|
7.1 | (1.9 | ) | |||||
Net realized investment gains (losses)
|
(1.0 | ) | .1 | |||||
Amortization related to net realized investment gains (losses)
|
.4 | .6 | ||||||
Net realized investment gains (losses), net of related amortization
|
(.6 | ) | .7 | |||||
Income (loss) before income taxes
|
$ | 6.5 | $ | (1.2 | ) |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Health benefit ratios:
|
||||||||
All health lines:
|
||||||||
Insurance policy benefits
|
$ | 17.8 | $ | 14.9 | ||||
Benefit ratio (a)
|
225.0 | % | 178.3 | % | ||||
Long-term care:
|
||||||||
Insurance policy benefits
|
$ | 17.2 | $ | 14.3 | ||||
Benefit ratio (a)
|
235.7 | % | 187.2 | % | ||||
Interest-adjusted benefit ratio (b)
|
148.0 | % | 96.8 | % | ||||
Other health:
|
||||||||
Insurance policy benefits
|
$ | .6 | $ | .6 | ||||
Benefit ratio (a)
|
96.5 | % | 81.1 | % |
(a)
|
We calculate
benefit
ratios by dividing the related product’s insurance policy benefits by insurance policy income.
|
(b)
|
We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Other CNO Business long-term care products by dividing such product’s insurance policy benefits less interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Corporate operations:
|
||||||||
Interest expense on corporate debt
|
$ | (20.6 | ) | $ | (19.5 | ) | ||
Net investment income on other special-purpose portfolios
|
8.2 | .2 | ||||||
Fee revenue and other income
|
.4 | .5 | ||||||
Net operating results of variable interest entities
|
2.0 | 2.4 | ||||||
Loss on extinguishment of debt
|
(1.4 | ) | (1.8 | ) | ||||
Other operating costs and expenses
|
(11.1 | ) | (8.1 | ) | ||||
Loss before net realized investment losses and income taxes
|
(22.5 | ) | (26.3 | ) | ||||
Net realized investment losses
|
(1.1 | ) | (1.3 | ) | ||||
Loss before income taxes
|
$ | (23.6 | ) | $ | (27.6 | ) |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Premiums collected by product:
|
||||||||
Annuities:
|
||||||||
Fixed index (first-year)
|
$ | 148.2 | $ | 104.0 | ||||
Other fixed rate (first-year)
|
73.1 | 119.1 | ||||||
Other fixed rate (renewal)
|
.9 | 1.1 | ||||||
Subtotal - other fixed rate annuities
|
74.0 | 120.2 | ||||||
Total annuities
|
222.2 | 224.2 | ||||||
Health:
|
||||||||
Medicare supplement (first-year)
|
25.1 | 27.2 | ||||||
Medicare supplement (renewal)
|
153.7 | 149.4 | ||||||
Subtotal - Medicare supplement
|
178.8 | 176.6 | ||||||
Long-term care (first-year)
|
6.1 | 4.8 | ||||||
Long-term care (renewal)
|
138.8 | 144.7 | ||||||
Subtotal - long-term care
|
144.9 | 149.5 | ||||||
PDP and PFFS (first year)
|
.4 | 1.4 | ||||||
PDP and PFFS (renewal)
|
10.6 | 16.7 | ||||||
Subtotal – PDP and PFFS
|
11.0 | 18.1 | ||||||
Other health (first-year)
|
.4 | .6 | ||||||
Other health (renewal)
|
2.5 | 2.3 | ||||||
Subtotal - other health
|
2.9 | 2.9 | ||||||
Total health
|
337.6 | 347.1 | ||||||
Life insurance:
|
||||||||
First-year
|
24.7 | 20.2 | ||||||
Renewal
|
31.7 | 26.3 | ||||||
Total life insurance
|
56.4 | 46.5 | ||||||
Collections on insurance products:
|
||||||||
Total first-year premium collections on insurance products
|
278.0 | 277.3 | ||||||
Total renewal premium collections on insurance products
|
338.2 | 340.5 | ||||||
Total collections on insurance products
|
$ | 616.2 | $ | 617.8 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Premiums collected by product:
|
||||||||
Health:
|
||||||||
Medicare supplement (first-year)
|
$ | .6 | $ | 1.2 | ||||
Medicare supplement (renewal)
|
34.7 | 39.5 | ||||||
Subtotal - Medicare supplement
|
35.3 | 40.7 | ||||||
Supplemental health (first-year)
|
13.2 | 12.5 | ||||||
Supplemental health (renewal)
|
93.3 | 87.1 | ||||||
Subtotal – supplemental health
|
106.5 | 99.6 | ||||||
Other health (all renewal)
|
1.0 | 1.1 | ||||||
Total health
|
142.8 | 141.4 | ||||||
Life insurance:
|
||||||||
First-year
|
.4 | .2 | ||||||
Renewal
|
3.9 | 4.2 | ||||||
Total life insurance
|
4.3 | 4.4 | ||||||
Collections on insurance products:
|
||||||||
Total first-year premium collections on insurance products
|
14.2 | 13.9 | ||||||
Total renewal premium collections on insurance products
|
132.9 | 131.9 | ||||||
Total collections on insurance products
|
$ | 147.1 | $ | 145.8 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Premiums collected by product:
|
||||||||
Life insurance:
|
||||||||
First-year
|
$ | 8.7 | $ | 7.9 | ||||
Renewal
|
40.7 | 39.4 | ||||||
Total life insurance
|
49.4 | 47.3 | ||||||
Health (all renewal):
|
||||||||
Medicare supplement
|
1.3 | 1.5 | ||||||
Other health
|
.2 | .1 | ||||||
Total health
|
1.5 | 1.6 | ||||||
Collections on insurance products:
|
||||||||
Total first-year premium collections on insurance products
|
8.7 | 7.9 | ||||||
Total renewal premium collections on insurance products
|
42.2 | 41.0 | ||||||
Total collections on insurance products
|
$ | 50.9 | $ | 48.9 |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Premiums collected by product:
|
||||||||
Annuities:
|
||||||||
Fixed index (first-year)
|
$ | 2.7 | $ | 3.5 | ||||
Fixed index (renewal)
|
.9 | 1.2 | ||||||
Subtotal - fixed index annuities
|
3.6 | 4.7 | ||||||
Other fixed rate (first-year)
|
.4 | .2 | ||||||
Other fixed rate (renewal)
|
.2 | .2 | ||||||
Subtotal - other fixed rate annuities
|
.6 | .4 | ||||||
Total annuities
|
4.2 | 5.1 | ||||||
Health:
|
||||||||
Long-term care (all renewal)
|
7.4 | 7.7 | ||||||
Other health (all renewal)
|
.6 | .7 | ||||||
Total health
|
8.0 | 8.4 | ||||||
Life insurance:
|
||||||||
First-year
|
.4 | .6 | ||||||
Renewal
|
46.0 | 49.6 | ||||||
Total life insurance
|
46.4 | 50.2 | ||||||
Collections on insurance products:
|
||||||||
Total first-year premium collections on insurance products
|
3.5 | 4.3 | ||||||
Total renewal premium collections on insurance products
|
55.1 | 59.4 | ||||||
Total collections on insurance products
|
$ | 58.6 | $ | 63.7 |
March 31,
|
December 31,
|
|||||||
2011
|
2010
|
|||||||
Total capital:
|
||||||||
Corporate notes payable
|
$ | 949.8 | $ | 998.5 | ||||
Shareholders’ equity:
|
||||||||
Common stock
|
2.5 | 2.5 | ||||||
Additional paid-in capital
|
4,426.1 | 4,424.2 | ||||||
Accumulated other comprehensive income
|
257.6 | 238.3 | ||||||
Accumulated deficit
|
(285.8 | ) | (339.7 | ) | ||||
Total shareholders’ equity
|
4,400.4 | 4,325.3 | ||||||
Total capital
|
$ | 5,350.2 | $ | 5,323.8 | ||||
March 31,
|
December 31,
|
|||||||
2011
|
2010
|
|||||||
Book value per common share
|
$ | 17.50 | $ | 17.23 | ||||
Book value per common share, excluding accumulated other comprehensive income (a)
|
16.48 | 16.28 | ||||||
Ratio of earnings to fixed charges
|
1.80 | X | 1.68 | X | ||||
Debt to total capital ratios:
|
||||||||
Corporate debt to total capital (b)
|
17.8 | % | 18.8 | % | ||||
Corporate debt to total capital, as defined in our Senior Secured Credit Agreement (a)
|
19.2 | % | 20.0 | % |
(a)
|
This non-GAAP measure differs from the corresponding GAAP measure presented immediately above, because accumulated other comprehensive income has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income. Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. However, this measure does not replace the corresponding GAAP measure.
|
(b)
|
Such ratios excludes accumulated other comprehensive income from total capital. In addition, debt is defined as par value plus accrued interest and certain other items. Management believes this non-GAAP measure is useful as the level of such ratio impacts certain provisions in our Senior Secured Credit Agreement.
|
Amount
|
Maturity
|
Interest rate
|
|||
borrowed
|
date
|
at March 31, 2011
|
|||
$ | 100.0 |
October 2013
|
Variable rate – 0.580%
|
||
67.0 |
February 2014
|
Fixed rate – 1.830%
|
|||
100.0 |
September 2015
|
Variable rate – 0.600%
|
|||
100.0 |
September 2015
|
Variable rate – 0.604%
|
|||
100.0 |
October 2015
|
Variable rate – 0.610%
|
|||
150.0 |
October 2015
|
Variable rate – 0.605%
|
|||
146.0 |
November 2015
|
Fixed rate – 5.300%
|
|||
100.0 |
November 2015
|
Fixed rate – 4.890%
|
|||
100.0 |
December 2015
|
Fixed rate – 4.710%
|
|||
50.0 |
November 2016
|
Variable rate – 0.580%
|
|||
50.0 |
November 2016
|
Variable rate – 0.718%
|
|||
100.0 |
October 2017
|
Variable rate – 0.733%
|
|||
37.0 |
November 2017
|
Fixed rate – 3.750%
|
|||
$ | 1,200.0 |
Earned surplus
|
||||||
Subsidiary of CDOC
|
(deficit)
|
Additional information
|
||||
Subsidiaries of Conseco Life of Texas:
|
||||||
Bankers Life
|
$ | 147.2 |
(a)
|
|||
Colonial Penn
|
(239.5 | ) |
(b)
|
(a)
|
Bankers Life paid ordinary dividends of $50.0 million to Conseco Life of Texas in the first quarter of 2011.
|
(b)
|
The deficit is primarily due to transactions which occurred several years ago, including a tax planning transaction and the fee paid to recapture a block of business previously ceded to an unaffiliated insurer.
|
Principal
|
||||
Remainder of 2011
|
$ | 25.0 | ||
2012
|
45.0 | |||
2013
|
80.0 | |||
2014
|
75.0 | |||
2015
|
85.0 | |||
2016
|
383.0 | |||
2018
|
275.0 | |||
$ | 968.0 |
Gross
|
Gross
|
Estimated
|
||||||||||||||
Amortized
|
unrealized
|
unrealized
|
fair
|
|||||||||||||
cost
|
gains
|
losses
|
value
|
|||||||||||||
Investment grade (a):
|
||||||||||||||||
Corporate securities
|
$ | 12,781.7 | $ | 597.4 | $ | (115.3 | ) | $ | 13,263.8 | |||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
281.7 | 4.1 | (13.1 | ) | 272.7 | |||||||||||
States and political subdivisions
|
1,819.6 | 12.7 | (80.6 | ) | 1,751.7 | |||||||||||
Debt securities issued by foreign governments
|
.8 | .1 | - | .9 | ||||||||||||
Asset-backed securities
|
640.0 | 16.7 | (4.9 | ) | 651.8 | |||||||||||
Collateralized debt obligations
|
165.7 | 4.3 | - | 170.0 | ||||||||||||
Commercial mortgage-backed securities
|
1,327.2 | 80.2 | (5.4 | ) | 1,402.0 | |||||||||||
Mortgage pass-through securities
|
27.5 | 1.9 | (.1 | ) | 29.3 | |||||||||||
Collateralized mortgage obligations
|
1,321.0 | 20.8 | (31.8 | ) | 1,310.0 | |||||||||||
Total investment grade fixed maturities, available for sale
|
18,365.2 | 738.2 | (251.2 | ) | 18,852.2 | |||||||||||
Below-investment grade (a):
|
||||||||||||||||
Corporate securities
|
1,168.4 | 30.8 | (27.6 | ) | 1,171.6 | |||||||||||
Asset-backed securities
|
66.9 | 3.6 | (.2 | ) | 70.3 | |||||||||||
Collateralized debt obligations
|
14.5 | 1.7 | - | 16.2 | ||||||||||||
Commercial mortgage-backed securities
|
4.1 | - | (1.1 | ) | 3.0 | |||||||||||
Collateralized mortgage obligations
|
724.8 | 16.1 | (2.0 | ) | 738.9 | |||||||||||
Total below-investment grade fixed maturities, available for sale
|
1,978.7 | 52.2 | (30.9 | ) | 2,000.0 | |||||||||||
Total fixed maturities, available for sale
|
$ | 20,343.9 | $ | 790.4 | $ | (282.1 | ) | $ | 20,852.2 | |||||||
Equity securities
|
$ | 104.9 | $ | .6 | $ | (.1 | ) | $ | 105.4 |
(a)
|
Investment ratings – Investment ratings are assigned the second lowest rating by a nationally recognized statistical rating organization (Moody’s, S&P or Fitch Ratings (“Fitch”)), or if not rated by such firms, the rating assigned by the NAIC. NAIC designations of “1” or “2” include fixed maturities generally rated investment grade (rated “Baa3” or higher by Moody’s or rated “BBB-” or higher by S&P and Fitch). NAIC designations of “3” through “6” are referred to as below-investment grade (which generally are rated “Ba1” or lower by Moody’s or rated “BB+” or lower by S&P and Fitch). References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.
|
Percent of
|
||||||||||||||||
Gross
|
gross
|
|||||||||||||||
Percent of
|
unrealized
|
unrealized
|
||||||||||||||
Carrying value
|
fixed maturities
|
losses
|
losses
|
|||||||||||||
Collateralized mortgage obligations
|
$ | 2,048.9 | 9.8 | % | $ | 33.8 | 12.0 | % | ||||||||
Energy/pipelines
|
2,035.3 | 9.8 | 15.1 | 5.4 | ||||||||||||
Utilities
|
1,829.8 | 8.8 | 7.0 | 2.5 | ||||||||||||
States and political subdivisions
|
1,751.7 | 8.4 | 80.6 | 28.6 | ||||||||||||
Commercial mortgage-backed securities
|
1,405.0 | 6.7 | 6.5 | 2.3 | ||||||||||||
Insurance
|
1,271.5 | 6.1 | 14.2 | 5.0 | ||||||||||||
Food/beverage
|
1,091.0 | 5.2 | 11.7 | 4.1 | ||||||||||||
Healthcare/pharmaceuticals
|
986.6 | 4.7 | 6.9 | 2.5 | ||||||||||||
Banks
|
858.2 | 4.1 | 28.2 | 10.0 | ||||||||||||
Real estate/REITs
|
851.3 | 4.1 | 2.0 | .7 | ||||||||||||
Cable/media
|
747.1 | 3.6 | 14.9 | 5.3 | ||||||||||||
Asset-backed securities
|
722.1 | 3.5 | 5.1 | 1.8 | ||||||||||||
Transportation
|
548.1 | 2.6 | 1.9 | .7 | ||||||||||||
Capital goods
|
514.8 | 2.5 | 4.3 | 1.5 | ||||||||||||
Telecom
|
452.6 | 2.2 | 5.8 | 2.1 | ||||||||||||
Building materials
|
425.2 | 2.0 | 11.0 | 3.9 | ||||||||||||
Aerospace/defense
|
374.9 | 1.8 | 1.6 | .6 | ||||||||||||
Chemicals
|
323.5 | 1.5 | 1.6 | .6 | ||||||||||||
Paper
|
285.8 | 1.4 | 3.2 | 1.1 | ||||||||||||
Metals and mining
|
282.0 | 1.4 | 2.3 | .8 | ||||||||||||
U.S. Treasury and Obligations
|
272.7 | 1.3 | 13.1 | 4.6 | ||||||||||||
Brokerage
|
237.2 | 1.1 | 3.5 | 1.2 | ||||||||||||
Consumer products
|
227.3 | 1.1 | 4.3 | 1.5 | ||||||||||||
Other
|
1,309.6 | 6.3 | 3.5 | 1.2 | ||||||||||||
Total fixed maturities, available for sale
|
$ | 20,852.2 | 100.0 | % | $ | 282.1 | 100.0 | % |
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Fixed maturity securities, available for sale:
|
||||||||
Realized gains on sale
|
$ | 41.2 | $ | 48.5 | ||||
Realized losses on sale
|
(24.6 | ) | (31.2 | ) | ||||
Impairments:
|
||||||||
Total other-than-temporary impairment losses
|
(6.5 | ) | (4.2 | ) | ||||
Other-than-temporary impairment losses recognized in accumulated other comprehensive income (loss)
|
- | (2.6 | ) | |||||
Net impairment losses recognized
|
(6.5 | ) | (6.8 | ) | ||||
Net realized investment gains from fixed maturities
|
10.1 | 10.5 | ||||||
Commercial mortgage loans
|
(.4 | ) | .1 | |||||
Impairments of mortgage loans and other investments
|
(6.8 | ) | (13.5 | ) | ||||
Other
|
2.2 | (2.0 | ) | |||||
Net realized investment gains (losses)
|
$ | 5.1 | $ | (4.9 | ) |
Estimated
|
||||||||
Amortized
|
fair
|
|||||||
cost
|
value
|
|||||||
(Dollars in millions)
|
||||||||
Due in one year or less
|
$ | 10.1 | $ | 10.1 | ||||
Due after one year through five years
|
114.1 | 112.3 | ||||||
Due after five years through ten years
|
452.1 | 433.7 | ||||||
Due after ten years
|
4,799.3 | 4,582.9 | ||||||
Subtotal
|
5,375.6 | 5,139.0 | ||||||
Structured securities
|
1,064.3 | 1,018.8 | ||||||
Total
|
$ | 6,439.9 | $ | 6,157.8 |
Number
|
Cost
|
Unrealized
|
Estimated
|
|||||||||||||
of issuers
|
basis
|
loss
|
fair value
|
|||||||||||||
Less than 6 months
|
1 | $ | 14.9 | $ | (3.0 | ) | $ | 11.9 | ||||||||
Greater than or equal to 6 months and less than 12 months
|
1 | 3.2 | (.7 | ) | 2.5 | |||||||||||
Greater than 12 months
|
1 | 4.0 | (1.1 | ) | 2.9 | |||||||||||
3 | $ | 22.1 | $ | (4.8 | ) | $ | 17.3 |
Investment grade
|
Below investment grade
|
Total gross
|
|||||||||||||||||||
B+ and
|
unrealized
|
||||||||||||||||||||
AAA/AA/A
|
BBB
|
BB
|
below
|
losses
|
|||||||||||||||||
States and political subdivisions
|
$ | 53.6 | $ | 27.0 | $ | - | $ | - | $ | 80.6 | |||||||||||
Collateralized mortgage obligations
|
31.4 | .4 | - | 2.0 | 33.8 | ||||||||||||||||
Banks
|
12.0 | 14.0 | 2.2 | - | 28.2 | ||||||||||||||||
Energy/pipelines
|
1.0 | 14.0 | .2 | - | 15.2 | ||||||||||||||||
Cable/media
|
.2 | 6.7 | 2.8 | 5.2 | 14.9 | ||||||||||||||||
Insurance
|
4.9 | 8.8 | .5 | - | 14.2 | ||||||||||||||||
U.S. Treasury and Obligations
|
13.1 | - | - | - | 13.1 | ||||||||||||||||
Food/beverage
|
.2 | 11.0 | - | .5 | 11.7 | ||||||||||||||||
Building materials
|
- | 4.8 | 6.0 | .1 | 10.9 | ||||||||||||||||
Utilities
|
2.9 | 3.3 | - | .8 | 7.0 | ||||||||||||||||
Healthcare/pharmaceuticals
|
2.2 | 4.2 | .5 | - | 6.9 | ||||||||||||||||
Commercial mortgage-backed securities
|
2.3 | 3.1 | 1.1 | - | 6.5 | ||||||||||||||||
Telecom
|
3.6 | 1.4 | .7 | - | 5.7 | ||||||||||||||||
Asset-backed securities
|
1.5 | 3.4 | - | .2 | 5.1 | ||||||||||||||||
Capital goods
|
1.2 | 1.2 | 1.9 | - | 4.3 | ||||||||||||||||
Consumer products
|
.1 | 2.1 | 1.8 | .3 | 4.3 | ||||||||||||||||
Brokerage
|
1.8 | 1.7 | - | - | 3.5 | ||||||||||||||||
Paper
|
- | 1.1 | 2.1 | - | 3.2 | ||||||||||||||||
Metals and mining
|
- | 2.3 | - | - | 2.3 | ||||||||||||||||
Real estate/REITs
|
.1 | .6 | 1.2 | .1 | 2.0 | ||||||||||||||||
Transportation
|
.4 | 1.5 | - | - | 1.9 | ||||||||||||||||
Aerospace/defense
|
1.6 | - | - | - | 1.6 | ||||||||||||||||
Chemicals
|
- | 1.5 | .1 | - | 1.6 | ||||||||||||||||
Retail
|
.3 | .4 | - | - | .7 | ||||||||||||||||
Technology
|
.1 | .5 | - | - | .6 | ||||||||||||||||
Gaming
|
- | - | - | .3 | .3 | ||||||||||||||||
Autos
|
- | .2 | - | - | .2 | ||||||||||||||||
Textiles
|
- | - | - | .2 | .2 | ||||||||||||||||
Mortgage pass-through securities
|
.1 | - | - | - | .1 | ||||||||||||||||
Other
|
- | 1.4 | .1 | - | 1.5 | ||||||||||||||||
Total fixed maturities, available for sale
|
$ | 134.6 | $ | 116.6 | $ | 21.2 | $ | 9.7 | $ | 282.1 |
Less than 12 months
|
12 months or greater
|
Total
|
||||||||||||||||||||||
Fair
|
Unrealized
|
Fair
|
Unrealized
|
Fair
|
Unrealized
|
|||||||||||||||||||
Description of securities
|
value
|
losses
|
value
|
losses
|
value
|
losses
|
||||||||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
$ | 206.3 | $ | (13.1 | ) | $ | .3 | $ | - | $ | 206.6 | $ | (13.1 | ) | ||||||||||
States and political subdivisions
|
1,016.2 | (41.5 | ) | 212.7 | (39.1 | ) | 1,228.9 | (80.6 | ) | |||||||||||||||
Corporate securities
|
2,955.2 | (83.0 | ) | 748.3 | (59.9 | ) | 3,703.5 | (142.9 | ) | |||||||||||||||
Asset-backed securities
|
211.2 | (4.1 | ) | 10.5 | (1.0 | ) | 221.7 | (5.1 | ) | |||||||||||||||
Collateralized debt obligations
|
1.7 | - | - | - | 1.7 | - | ||||||||||||||||||
Commercial mortgage-backed securities
|
60.0 | (.7 | ) | 69.0 | (5.8 | ) | 129.0 | (6.5 | ) | |||||||||||||||
Mortgage pass-through securities
|
.2 | - | 3.3 | (.1 | ) | 3.5 | (.1 | ) | ||||||||||||||||
Collateralized mortgage obligations
|
626.5 | (32.6 | ) | 36.4 | (1.2 | ) | 662.9 | (33.8 | ) | |||||||||||||||
Total fixed maturities, available for sale
|
$ | 5,077.3 | $ | (175.0 | ) | $ | 1,080.5 | $ | (107.1 | ) | $ | 6,157.8 | $ | (282.1 | ) |
Par
|
Amortized
|
Estimated
|
||||||||||
value
|
cost
|
fair value
|
||||||||||
Below 4 percent
|
$ | 300.6 | $ | 272.7 | $ | 278.8 | ||||||
4 percent – 5 percent
|
520.7 | 510.0 | 482.1 | |||||||||
5 percent – 6 percent
|
2,529.9 | 2,449.9 | 2,534.1 | |||||||||
6 percent – 7 percent
|
896.7 | 850.3 | 880.3 | |||||||||
7 percent – 8 percent
|
118.6 | 119.9 | 125.7 | |||||||||
8 percent and above
|
90.3 | 88.9 | 90.5 | |||||||||
Total structured securities
|
$ | 4,456.8 | $ | 4,291.7 | $ | 4,391.5 |
Estimated fair value
|
||||||||||||
Percent
|
||||||||||||
Amortized
|
of fixed
|
|||||||||||
Type
|
cost
|
Amount
|
maturities
|
|||||||||
Pass-throughs, sequential and equivalent securities
|
$ | 1,412.7 | $ | 1,417.6 | 6.8 | % | ||||||
Planned amortization classes, target amortization classes and accretion-directed bonds
|
622.6 | 622.8 | 3.0 | |||||||||
Commercial mortgage-backed securities
|
1,331.3 | 1,405.0 | 6.7 | |||||||||
Asset-backed securities
|
706.9 | 722.1 | 3.5 | |||||||||
Collateralized debt obligations
|
180.2 | 186.2 | .9 | |||||||||
Other
|
38.0 | 37.8 | .2 | |||||||||
Total structured securities
|
$ | 4,291.7 | $ | 4,391.5 | 21.1 | % |
Estimated fair
|
||||||||
Loan-to-value ratio (a)
|
Carrying value
|
value
|
||||||
Less than 60%
|
$ | 698.0 | $ | 744.8 | ||||
60% to 70%
|
680.5 | 659.1 | ||||||
70% to 80%
|
256.4 | 250.9 | ||||||
80% to 90%
|
59.3 | 57.7 | ||||||
Greater than 90%
|
57.1 | 49.6 | ||||||
Total
|
$ | 1,751.3 | $ | 1,762.1 |
(a)
|
Loan-to-value ratios are calculated as the ratio of: (i) the carrying value of the commercial mortgage loans; to (ii) the estimated fair value of the underlying commercial property.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2011
|
2010
|
|||||||
Revenues:
|
||||||||
Net investment income – policyholder and reinsurer accounts and other special-purpose portfolios
|
$ | 4.4 | $ | 5.4 | ||||
Fee revenue and other income
|
.2 | .2 | ||||||
Total revenues
|
4.6 | 5.6 | ||||||
Expenses:
|
||||||||
Interest expense
|
2.5 | 3.0 | ||||||
Other operating expenses
|
.1 | .2 | ||||||
Total expenses
|
2.6 | 3.2 | ||||||
Income before net realized investment losses and income taxes
|
2.0 | 2.4 | ||||||
Net realized investment losses
|
(1.4 | ) | (1.3 | ) | ||||
Income before income taxes
|
$ | .6 | $ | 1.1 |
Percent of
|
||||||||||||||||
Percent
|
Gross
|
gross
|
||||||||||||||
of fixed
|
unrealized
|
unrealized
|
||||||||||||||
Carrying value
|
maturities
|
losses
|
losses
|
|||||||||||||
Cable/media
|
$ | 63.8 | 15.9 | % | $ | .3 | 12.4 | % | ||||||||
Healthcare/pharmaceuticals
|
55.3 | 13.8 | .3 | 13.1 | ||||||||||||
Chemicals
|
23.9 | 5.9 | .1 | 3.6 | ||||||||||||
Retail
|
22.3 | 5.6 | .1 | 2.4 | ||||||||||||
Entertainment/hotels
|
19.0 | 4.7 | .5 | 17.4 | ||||||||||||
Gaming
|
18.8 | 4.7 | .1 | 1.8 | ||||||||||||
Food/beverage
|
18.7 | 4.7 | - | 1.6 | ||||||||||||
Autos
|
18.6 | 4.6 | - | 1.1 | ||||||||||||
Consumer products
|
14.7 | 3.7 | .1 | 4.2 | ||||||||||||
Paper
|
14.1 | 3.5 | - | .3 | ||||||||||||
Insurance
|
11.4 | 2.8 | - | - | ||||||||||||
Capital goods
|
11.3 | 2.8 | .1 | 3.2 | ||||||||||||
Technology
|
11.1 | 2.8 | .1 | 2.5 | ||||||||||||
Aerospace/defense
|
11.1 | 2.8 | - | - | ||||||||||||
Utilities
|
10.2 | 2.5 | .5 | 19.2 | ||||||||||||
Energy/pipelines
|
8.7 | 2.2 | .1 | 5.6 | ||||||||||||
Brokerage
|
7.1 | 1.8 | - | - | ||||||||||||
Transportation
|
6.1 | 1.5 | - | .4 | ||||||||||||
Building materials
|
4.0 | 1.0 | - | - | ||||||||||||
Other
|
51.4 | 12.7 | .3 | 11.2 | ||||||||||||
Total
|
$ | 401.6 | 100.0 | % | $ | 2.6 | 100.0 | % |
Estimated
|
||||||||
Amortized
|
fair
|
|||||||
cost
|
value
|
|||||||
(Dollars in millions)
|
||||||||
Due in one year or less
|
$ | 3.1 | $ | 3.1 | ||||
Due after one year through five years
|
163.5 | 160.9 | ||||||
Due after five years through ten years
|
1.9 | 1.9 | ||||||
Total
|
$ | 168.5 | $ | 165.9 |
Period
|
Total number of
shares (or units)
|
Average price paid per share
(or unit)
|
Total number of shares (or units) purchased as part of publicly announced
plans or programs
|
Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the
plans or programs
(a)
|
||||||||||||
(dollars in millions)
|
||||||||||||||||
January 1 through January 31
|
- | $ | - | - | $ | 262.8 | ||||||||||
February 1 through February 28
|
- | - | - | 262.8 | ||||||||||||
March 1 through March 31
|
149,515 | 7.24 | - | 262.8 | ||||||||||||
Total
|
149,515 | 7.24 | - | 262.8 |
(a)
|
On December 21, 2006, the Company announced a common share repurchase program of up to $150 million. On May 8, 2007, the Company announced that the maximum amount that was authorized under the common share repurchase program had been increased to $350 million.
|
12.1
|
Computation of Ratio of Earnings to Fixed Charges.
|
31.1
|
Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
31.2
|
Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
32.1
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
32.2
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
101
|
The following materials from CNO Financial Group, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheet; (ii) Consolidated Statement of Operations; (iii) Consolidated Statement of Shareholders’ Equity; (iv) Consolidated Statement of Cash Flows; and (v) Notes to Consolidated Financial Statements, tagged as blocks of text.
|
By:
|
/s/ Edward J. Bonach
|
|
Edward J. Bonach
|
||
Executive Vice President and Chief Financial Officer
|
||
(authorized officer and principal financial officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Suppliers
Supplier name | Ticker |
---|---|
Johnson & Johnson | JNJ |
Pfizer Inc. | PFE |
Merck & Co., Inc. | MRK |
Abbott Laboratories | ABT |
Bristol-Myers Squibb Company | BMY |
AbbVie Inc. | ABBV |
Amgen Inc. | AMGN |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|